首页> 外国专利> COMPOUNDS INFLUENCING DEVELOPMENT OR FUNCTIONING OF CELLULAR VESICULAR SYSTEMS PARTICULARLY LIPID DROPLETS, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND USE THEM FOR TREATMENT OF ILLNESSES

COMPOUNDS INFLUENCING DEVELOPMENT OR FUNCTIONING OF CELLULAR VESICULAR SYSTEMS PARTICULARLY LIPID DROPLETS, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND USE THEM FOR TREATMENT OF ILLNESSES

机译:影响细胞囊泡系统(尤其是脂质液滴),包含这些化合物的药物组合物的开发或功能的化合物,并将其用于治疗疾病

摘要

The present invention relates to compounds that are suitable for treatment of disease states and influence cellular vesicular systems, especially the formation and/or function of lipid droplets, said compound having the general formula I (I) wherein X are each independently hydrogen, halogen, C1-20-alkyl, C2-20-alkenyl, C2-20-alkinyl, C5-6-cykloalkyl, aryl, aralkyl, adamantyl, heterocyclic, hydroxyl, hydroxyalkyl, Or N(R1, R2) group; n is 0, 1, 2, 3, or 4; R1 and R2 may each be independently hydrogen, straight or branching alkyl, cyclo-alkyl, aryl, aralkyl, heterocyclic group, wherein each is un-substituted or halogen substituted; or R1 and R2 together with the nitrogen in between them form a 5 or 6 member ring; A is a single bond, O, S, CH2-, or NH; Y is O or S; Z is O or S; R and R are each independently methyl, ethyl, isopropyl, isobuthyl, sec-butyl or terc-butyl; with the restriction that: X(n) cannot all be fluorine, and A be a single bond, and Y, as well as Z be O, and R, as well as R be isopropyl, and R1 and R2 be hydrogen at the same time. The present invention further relates to pharmaceutical compositions comprising such compounds and to use of such compounds for treatment of disease states.
机译:本发明涉及适合于治疗疾病状态并影响细胞泡系统的化合物,尤其是脂质滴的形成和/或功能,所述化合物具有通式I(I),其中X各自独立地为氢,卤素, C1-20-烷基,C2-20-烯基,C2-20-炔基,C5-6-环烷基,芳基,芳烷基,金刚烷基,杂环,羟基,羟烷基或N(R1,R2)基团; n为0、1、2、3或4; R1和R2可以各自独立地是氢,直链或支链烷基,环烷基,芳基,芳烷基,杂环基,其中每个均未被取代或被卤素取代; R1和R2与它们之间的氮一起形成5或6元环;或A为单键,O,S,CH 2-或NH; Y是O或S; Z为O或S; R 1和R 2各自独立地为甲基,乙基,异丙基,异丁基,仲丁基或叔丁基;限制为:X(n)不能全部都是氟,并且A是单键,并且Y,Z和Z是O,R和R是异丙基,并且R1和R2在同一位置上是氢时间。本发明进一步涉及包含此类化合物的药物组合物以及此类化​​合物在治疗疾病中的用途。

著录项

  • 公开/公告号HU0700433D0

    专利类型

  • 公开/公告日2007-08-28

    原文格式PDF

  • 申请/专利权人 AVICOR KFT.;

    申请/专利号HU20070000433

  • 发明设计人

    申请日2007-06-21

  • 分类号C07D419/02;A61K31/33;

  • 国家 HU

  • 入库时间 2022-08-21 20:58:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号